It's easy to understand how someone who gets hives for the first time could confuse the sudden appearance of raised, red, or skin-colored bumps with bug bites or other skin conditions, such as eczema.

A systematic review shows second generation antihistamines appear to be more effective and less sedating for patients managing chronic urticaria.

NEW YORK — The responsibility for diagnosing and treating chronic spontaneous urticaria (CSU), for which there is a newly approved drug, should be in the hands of dermatologists who have the skills, ...

Moderna COVID-19 vaccines were associated with a threefold increased risk of chronic urticaria and nearly fourfold increased risk of other types of urticaria compared to expected rates.

Pressure urticaria is a type of chronic urticaria that causes recurring hives from pressure applied to your skin. It may be treated with a combination of trigger avoidance and medications. Better ...

Outside the drug’s current urticaria niche, Novartis is also developing remibrutinib in myasthenia gravis and multiple ...

Hives (urticaria) are raised, itchy bumps on your skin. If you get itchy hives that come and go mostly every day for over six weeks, you might have a skin condition known as chronic spontaneous ...

SAN DIEGO — New insight into the roots of chronic spontaneous urticaria (CSU) and an expanding toolbox of therapies are transforming the understanding of the disease, a dermatologist told colleagues ...

Phase 3 trial results show remibrutinib significantly improves complete response rates in patients with 3 types of chronic inducible urticaria.

The trial is assessing remibrutinib's safety, tolerability and efficacy in adults with CIndU unresponsive to ...

Novartis reports positive topline results from pivotal phase III RemIND trial of oral remibrutinib in chronic inducible urticaria: Basel Thursday, February 19, 2026, 13:00 Hrs [IS ...